✦ LIBER ✦

269 Predicting response of invasive rectal cancer to brachytherapy by mathematical modeling of p21, bcl-2 and p53 immunohistochemistry

✍ Scribed by I. Zlobec; T. Vuong; C. Compton; S. Zlobec

Book ID: 118620444
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 174 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)90302-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P53 AND BCL-2 IMMUNOHISTOCHEMISTRY IN PR

P53 AND BCL-2 IMMUNOHISTOCHEMISTRY IN PRETREATMENT PROSTATE NEEDLE BIOPSIES TO PREDICT RECURRENCE OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMY

✍ STACKHOUSE, GEORGE B.; SESTERHENN, ISABELL A.; BAUER, JOHN J.; MOSTOFI, F. KASH; 📂 Article 📅 1999 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 78 KB

Predictive value of expression of P53, B

Predictive value of expression of P53, Bcl-2 and lung resistance-related protein for response to chemotherapy in non-small cell lung cancers

✍ Toshiyuki Harada; Shigeaki Ogura; Koichi Yamazaki; Ichiro Kinoshita; Tomoo Itoh; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB

A Study of the Value of p53, HER2, and B

A Study of the Value of p53, HER2, and Bcl-2 in the Prediction of Response to Doxorubicin and Paclitaxel as Single Agents in Metastatic Breast Cancer: A Companion Study to EORTC 10923

✍ A. Hamilton; D. Larsimont; R. Paridaens; M. Drijkoningen; M. van de Vijver; P. B 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 126 KB

Commentary on “A Study of the Value of p

Commentary on “A Study of the Value of p53, HER2, and Bcl-2 in the Prediction of Response to Doxorubicin and Paclitaxel as Single Agents in Metastatic Breast Cancer: A Companion Study to EORTC 10923”

✍ Vered Stearns; Daniel F. Hayes 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 53 KB

[ASCRIT] Antisense chemoradioimmunothera

[ASCRIT] Antisense chemoradioimmunotherapy consisting of anti-POEM (Arg-Gly-Asp) scFv linked onto high-energy radioisotopes, vinorelbine-tartrate and 21-nucleotide double-stranded siRNA targeted to DNMT1 induce apoptosis in metastatic breast cancer (MBC) characterized by hypermethylated p53, p16, RASSF1A, RAR-b2, BRCA2, H1C1, ESRI1, CDH1, Trbeta1, GSTP1, CCND2 and overexpression of bcl-2, cdc25c, Raf-1 and α8β1 integrin

✍ J Giannios, P Lambrinos, E Maragudakis, N Alexandropoulos 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 618 KB